BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17632404)

  • 1. Editorial comment: a role for alloimmune response mediators in tolerance induction?
    Monaco AP; Morris PJ
    Transplantation; 2007 Jul; 84(1 Suppl):S1-2. PubMed ID: 17632404
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of tolerance in clinical organ transplantation.
    Fändrich F
    Nephrol Dial Transplant; 2006 May; 21(5):1170-3. PubMed ID: 16504976
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP; Li Z; Nador RG; Strober S
    Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minor histocompatibility antigens: targets for tumour therapy and transplant tolerance.
    Spierings E
    Int J Immunogenet; 2008 Aug; 35(4-5):363-6. PubMed ID: 18976439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medawar Prize Lecture: tolerance and graft-vs-host disease: two sides of the same coin.
    Brent L
    Transplant Proc; 1995 Feb; 27(1):12-4. PubMed ID: 7878849
    [No Abstract]   [Full Text] [Related]  

  • 6. Protective role of bone marrow cells in controlling alloreactivity.
    Slavin S
    Transplantation; 2003 Jul; 76(2):436-7; author reply 437. PubMed ID: 12883209
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of interleukin-15 in umbilical cord blood transplantation.
    Lin SJ; Yan DC; Lee YC; Kuo ML
    Int Rev Immunol; 2008; 27(6):518-31. PubMed ID: 19065354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continued disease activity in a patient with multiple sclerosis after allogeneic hematopoietic cell transplantation.
    Lu JQ; Storek J; Metz L; Yong VW; Stevens AM; Nash RA; Joseph JT
    Arch Neurol; 2009 Jan; 66(1):116-20. PubMed ID: 19139309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
    He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX
    Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation.
    Mohty M; Gaugler B
    Cytokine Growth Factor Rev; 2008 Feb; 19(1):53-63. PubMed ID: 18083060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards specific immune tolerance of allografts.
    Griffiths PD
    Rev Med Virol; 2007; 17(6):367-9. PubMed ID: 17957729
    [No Abstract]   [Full Text] [Related]  

  • 12. B-cell involvement in chronic graft-versus-host disease.
    Kapur R; Ebeling S; Hagenbeek A
    Haematologica; 2008 Nov; 93(11):1702-11. PubMed ID: 18728020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches to the prevention of organ allograft rejection and tolerance induction.
    Bagley J; Tian C; Iacomini J
    Transplantation; 2007 Jul; 84(1 Suppl):S38-41. PubMed ID: 17632412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells, tolerance induction and transplant outcome.
    Coates PT; Thomson AW
    Am J Transplant; 2002 Apr; 2(4):299-307. PubMed ID: 12118850
    [No Abstract]   [Full Text] [Related]  

  • 15. Frontiers in nephrology: the varied faces of natural killer cells in transplantation--contributions to both allograft immunity and tolerance.
    Beilke JN; Gill RG
    J Am Soc Nephrol; 2007 Aug; 18(8):2262-7. PubMed ID: 17634430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yin and yang of cytokine regulation in solid organ graft rejection and tolerance.
    Wadia PP; Tambur AR
    Clin Lab Med; 2008 Sep; 28(3):469-79, vii-viii. PubMed ID: 19028264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells can affect solid organ allograft survival.
    Popp FC; Eggenhofer E; Renner P; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
    Transplantation; 2009 May; 87(9 Suppl):S57-62. PubMed ID: 19424009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal photopheresis: Lighting the way to immunomodulation.
    Babic AM
    Am J Hematol; 2008 Jul; 83(7):589-91. PubMed ID: 18335565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges to achieving clinical transplantation tolerance.
    Salama AD; Remuzzi G; Harmon WE; Sayegh MH
    J Clin Invest; 2001 Oct; 108(7):943-8. PubMed ID: 11581293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.